Lataa...
Does Treatment Response to Ambrisentan Vary by Pulmonary Arterial Hypertension Severity? Implications for Clinicians and for the Design of Future Clinical Trials
BACKGROUND: Recent clinical trials in pulmonary arterial hypertension have included World Health Organization (WHO) functional classes I–II patients. However, the impact of baseline functional class and other measures of severity on outcomes has not been evaluated in detail. METHODS: Outcomes at 12-...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4035243/ https://ncbi.nlm.nih.gov/pubmed/24499136 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.12331 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|